Background/Aims: To report the outcomes of transobturator tape (TOT) surgery with Safyre T® (Promedon, Argentina) slings for female stress urinary incontinence (SUI) at a 96- month follow-up. Methods: We conducted a clinical follow-up study of 153 patients diagnosed with SUI between January 2005 and December 2014. Patients were provided with detailed a priori information pertaining to the TOT procedure and were invited to attend follow-up visits at 1, 3, 12, 24, 48, 72 and 96 months. Follow-up visits included physical examination involving sling palpation, checking of the vaginal mucosa for erosion, cough test, as well as validated Urinary Distress Inventory-6 (UDI-6) and Incontinence Impact Questionnaire-7 (IIQ-7) questionnaires. Results: The overall objective success rates, based on cough test results, were 91.3% at 12 months, 86.8% at 48 months and 77.6% at 96 months. Similarly, the overall subjective success rate, based on the validated UDI-6 and IIQ-7 scales, was 77.6% at 96 months. Conclusion: The cure rates achieved, following TOT treatment of SUI at 1-year follow-up, showed a statistically significant decline over an 8-year period, especially at months 48 and 96.

Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN: An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 2010;21:25-26.
Hunskaar S, Lose G, Sykes D, Voss S: The prevalence of urinary incontinence in women in four European countries. BJU Int 2004;93:324.
Kocaöz S, Eroğlu K, Sivaslıoğlu AA: Role of pelvic floor muscle exercises in the prevention of stress urinary incontinence during pregnancy and the postpartum period. Gynecol Obstet Invest 2013;75:34-40.
Jäger W, Mirenska O, Brügge S: Surgical treatment of mixed and urge urinary incontinence in women. Gynecol Obstet Invest 2012;74:157-164.
Ward KL, Hilton P: Tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5-year follow up. Br J Obstet Gynaecol 2008;115:226-233.
Latthe PM, Foon R, Toozs-Hobson P: Transobturator and retropubic tape procedures in stress urinary incontinence: a systematic review and meta-analysis of effectiveness and complications. Br J Obstet Gynaecol 2007;114:522.
Padilla-Fernández B, García-Cenador MB, Gómez-García A, Mirón-Canelo JA, Gil- Vicente A, Silva-Abuín JM, Lorenzo-Gómez MF: Results of the surgical correction of stress incontinence according to the type of transobturator tape utilized. Arch Ital Urol Androl 2013;85:149-153.
Govier FE, Kobashi KC, Kozlowski PM, Kuznetsov DD, Begley SJ, McGonigle KF, Muntz HG: High complication rate identified in sacrocolpopexy patients attributed to silicone mesh. Urology 2005;65:1099-1103.
Yamada BS, Govier FE, Stefanovic KB, Kobashi KC: High rate of vaginal erosions associated with the mentor ObTape. J Urol 2006;176:651-654.
Palma P, Riccetto C, Herrmann V, Dambros M, Thiel M, Bandiera S, Netto NR Jr: Transobturator SAFYRE sling is as effective as the transvaginal procedure. Int Urogynecol J Pelvic Floor Dysfunct 2005;16:487-491.
Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA: Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn 1995;14:131-139.
Lemack GE, Zimmern PE: Predictability of urodynamic findings based on the Urogenital Distress Inventory-6 questionnaire. Urology 1999;54:461-466.
Delorme E: Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women. Prog Urol 2001;11:1306-1313.
Tınar Ş, Toz E: Stres inkontinanslı hastalarda subürethral transobturatuar tape uygulaması ile nöromuskuler elektrikli stimülatör tedavisinin karşılaştırılması. T.C. Sağlık Bakanlığı İzmir Ege Doğumevi ve Kadın Hastalıkları Eğitim ve Araştırma Hastanesi Kadın Hastalıkları ve Doğum Uzmanlık Tezi 2008.
Hunskaar S, Arnold EP, Burgio K, Diokno AC, Herzog AR, Mallett VT: Epidemiology and natural history of urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2000;11:301-319.
Reisenauer C, Muche-Borowski C, Anthuber C, et al: Interdisciplinary S2e Guideline for the Diagnosis and Treatment of Stress Urinary Incontinence in Women: Short version - AWMF Registry No. 015-005, July 2013. Geburtshilfe Frauenheilkd 2013;73:899-903.
Kuschel S, Schuessler B: Results on function and safety of the Safyre-t, a hybrid transobturator vaginal sling for the treatment of stress urinary incontinence. Neurourol Urodyn 2008;27:403-406.
Asıcıoglu O, Gungorduk K, Besımoglu B, Ertas IE, Yıldırım G, Celebı I, Ark C, Boran B: A 5-year follow-up study comparing Burch colposuspension and transobturator tape for the surgical treatment of stress urinary incontinence. Int J Gynaecol Obstet 2014;125:73-77.
Sivaslioglu AA, Caliskan E, Dolen I, Haberal A: A randomized comparison of transobturator tape and Burch colposuspension in the treatment of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2007;18:1015-1019.
Ballester M, Bui C, Frobert JL, Grisard-Anaf M, Lienhart J, Fernandez H, David-Montefiore E, Rouzier R, Daraï E: Four-year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes. World J Urol 2012;30:117-122.
Angioli R, Plotti F, Muzii L, Montera R, Panici PB, Zullo MA: Tension-free vaginal tape versus transobturator suburethral tape: five-year follow-up results of a prospective, randomized trial. Eur Urol 2010;58:671-677.
Heinonen P, Ala-Nissilä S, Räty R, Laurikainen E, Kiilholma P: Objective cure rates and patient satisfaction after the transobturator tape procedure during 6.5-year follow-up. J Minim Invasive Gynecol 2013;20:73-78.
Cañete P, Ortiz E, Domingo S, Cano A: Transobturator suburethral tape in the treatment of stress urinary incontinence: efficacy and quality of life after 5 year follow up. Maturitas 2013;74:166-171.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.